Found 16 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) PHASE3 The study is being conducted to demonstrate that V221 may be administered c...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children PHASE3 The purpose of this study is to assess the immunogenicity and safety of GSK...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age PHASE2 The purpose of this observer blinded study is to provide information on vac...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) PHASE4 Hepatitis A vaccine will be given either alone or together with measles, mu...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) PHASE3 The primary study objectives are:
* To demonstrate that a 2-dose regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of ProQuad™ in Healthy Children in Korea (V221-023) PHASE3 This study will compare ProQuad™ and concomitant administration of M-M-R™ I...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM PHASE3 The purpose of this study is to assess non-inferiority of two different vac...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children PHASE3 The purpose of this study is to demonstrate, in 12-23 month old children, t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) PHASE3 Primary Objective:
* To demonstrate that ProQuad® can be administered conc...
Show More Location
Multiple Locations
Learn More & Join Trial